Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Chronic Kidney Disease Market Growth From $79.42 Billion In 2026 To $101.86 Billion By 2030 At A CAGR Of 6.4%
The global market for chronic kidney disease (CKD) has witnessed significant expansion recently, forecasting a rise from $74.87 billion in 2025 to $79.43 billion in 2026, reflecting a compound annual growth rate of 6.1%. This historical growth trajectory has been propelled by factors such as the increasing incidence of diabetes and hypertension, enhanced access to dialysis facilities, advancements in diagnosing kidney function, greater public awareness concerning chronic kidney ailments, and the broadening scope of nephrology healthcare services.
The chronic kidney disease market is poised for considerable expansion over the forthcoming years, projected to reach a valuation of $101.87 billion by 2030, spurred by a compound annual growth rate of 6.4%. This anticipated market surge is fueled by several key factors, including the continuous innovation in novel renal treatments, a burgeoning demand for dialysis methods tailored to individual patient needs, the proliferation of digital tools for monitoring kidney health, a heightened emphasis on preparing patients for kidney transplants, and increased investment in preventative nephrology initiatives. Within this projected period, notable trends are expected to shape the landscape, such as a greater focus on identifying chronic kidney disease in its early stages, a wider uptake of renoprotective medications, increased utilization of home-based dialysis options, the broader implementation of integrated care approaches involving multiple medical disciplines, and a reinforced commitment to decelerating the advancement of the disease.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp
Chronic Kidney Disease Market Development Factors: Which Trends Are Supporting Demand?
The escalating incidence of kidney ailments is anticipated to fuel the expansion of the chronic kidney disease (CKD) market. Kidney diseases encompass a range of afflictions impacting the functional and structural integrity of the kidneys. Therapeutic interventions for kidney disease aim to regulate patient blood pressure and reduce protein leakage, thereby slowing the advancement of renal dysfunction, alleviating symptoms, and preventing complications. For example, projections by Kidney Research UK in June 2023 indicated that by 2033, the number of individuals experiencing CKD stages 3–5 in the UK is likely to reach approximately 3.9 million, underscoring the direct correlation between the rising prevalence of kidney disease and the market’s growth trajectory.
Chronic Kidney Disease Market Segments: Where Are The Largest Growth Opportunities?
The chronic kidney disease market covered in this report is segmented –
1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy
2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments
3) By Route of Administration: Oral, Intravenous, Subcutaneous
4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users
Subsegments:
1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests
2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)
3) By Imaging Test: Ultrasound, CT Scan, MRI, X-Ray
4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy
Chronic Kidney Disease Market Transformation Trends: Which Innovations Are Driving Change?
Key players within the chronic kidney disease sector are actively pursuing collaborations to scrutinize the safety and effectiveness of an advanced Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. This collaborative strategy involves entities combining their distinct advantages and resources to foster shared progress. A notable example occurred in June 2023 when AWAK Technologies Pte Ltd., a Singaporean medical tech firm, joined forces with Singapore General Hospital Pte Ltd. (SGH), an academic health science hub and hospital entity also located in Singapore. Through this alliance, their objective is to transform the identification, therapeutic interventions, and ongoing care for kidney ailments, specifically focusing on the creation and evaluation of a wearable and highly portable peritoneal dialysis (PD) system, branded as AWAK PD, designed to empower end-stage renal disease patients with the ability to perform dialysis sessions within their homes and during travel.
Chronic Kidney Disease Market Major Participants And Competitive Dynamics
Major companies operating in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp
Access The Complete Chronic Kidney Disease Market Report:
https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report
Chronic Kidney Disease Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the chronic kidney disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
